Lanxess shares slipped on Thursday as the German specialty‑chemicals maker reported weaker demand across its customer base. Competition from Asian rivals pushed the company to lower some prices, tightening margins and dampening sales volumes. The move signals that the anticipated rebound in the chemical sector remains elusive.

The price cuts came amid a broader slump in industrial demand, leaving Lanxess unable to sustain its previous growth trajectory. Investors reacted by selling shares, pushing the stock down by roughly 3% in after‑hours trading. The decline underscores the fragility of the specialty‑chemicals market in a global environment dominated by low‑cost producers.

Analysts note that the price reductions could erode profit margins further, especially if competitors maintain lower cost structures. A sustained decline in sales volumes may force Lanxess to reassess its product mix and cost base. The company’s current valuation reflects a cautious outlook, with investors demanding clearer evidence of demand recovery.

With the share price now trading below its 52‑week low, Lanxess faces mounting pressure to deliver a turnaround. The recent dip reflects a broader challenge for the specialty‑chemicals sector, where price wars and weak demand converge. Investors will watch closely for any sign that the company can reverse the downward trend.